SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-08-014927
Filing Date
2008-11-10
Accepted
2008-11-10 16:30:37
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y00527e10vq.htm 10-Q 234820
2 EX-31.1: CERTIFICATION y00527exv31w1.htm EX-31.1 8247
3 EX-31.2: CERTIFICATION y00527exv31w2.htm EX-31.2 8233
4 EX-32.1: CERTIFICATION y00527exv32w1.htm EX-32.1 3029
5 EX-32.2: CERTIFICATION y00527exv32w2.htm EX-32.2 3032
  Complete submission text file 0000950123-08-014927.txt   259019
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 081176062
SIC: 2836 Biological Products, (No Diagnostic Substances)